← FDA ENFORCEMENT
H-0623-2025Class II

Extract Labs, Inc.

Recalling firm
Extract Labs, Inc.
Product type
Food / supplement / cosmetic
Status
Terminated
Report date
2025-10-01
Distribution
Product distributed throughout the United States and Australia, Germany, United Kingdom, Malaysia, and New/Zealand.
Firm state
CO
Product quantity
19,810 gummies
Initiated by
Voluntary: Firm initiated
Reason for recall

Potential peanut protein cross-contact.

Product description

Blue Razz 20mg Gummies Brand Name: None - unlabeled bulk (private-label consignee) Generic Name: Dietary Supplement Strength: 20mg CBD and 20mg D9 THC per gummy Dosage: Not declared at bulk stage (consignee determines serving size) Form: Gummy Administration: Oral Intended use: Dietary supplement for further packaging/labeling by consignee Type of packaging: Shipped in poly gusset bags, inside corrugated brown boxes, no consumer label applied. Net wt. Blue Razz: 24 bags x 5kg and 1 bag x 4kg UPC: N/A (unlabeled bulk) Firm name & address: None (no consumer label)

Code / lot info

Lot: 25JD082307A EXP: 07/2027 Printed on bulk bag identifier adhesive

Data: U.S. FDA openFDA enforcement API. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification.